Free Trial

Ayala Pharmaceuticals (ADXS) Stock Chart & Stock Price History

Ayala Pharmaceuticals logo
$0.03 -0.08 (-74.77%)
(As of 11/20/2024 ET)

Ayala Pharmaceuticals Stock Price Performance

5 Day
Performance
0.00%
1 Month
Performance
0.00%
3 Month
Performance
+31.71%
6 Month
Performance
-91.00%
Year-To-Date
Performance
-95.95%
1 Year
Performance
-96.60%
Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock Chart for Thursday, November, 21, 2024

Ayala Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
11/20/2024$0.11$0.03
-74.31%
$0.03$0.031,548 shs$1.15 million
11/19/2024$0.11$0.11$0.11$0.031,882 shs$4.48 million
11/18/2024$0.03$0.11
+289.26%
$0.11$0.031,881 shs$4.48 million
11/15/2024$0.03$0.03$0.03$0.03739 shs$1.15 million
11/14/2024$0.03$0.03
-10.00%
$0.11$0.03739 shs$1.15 million
11/13/2024$0.03$0.03$0.78$0.032,416 shs$1.28 million
11/12/2024$0.03$0.03
+11.11%
$0.78$0.032,416 shs$1.28 million
11/11/2024$0.11$0.03
-74.31%
$0.03$0.03471 shs$1.15 million
11/08/2024$0.03$0.11
+287.82%
$0.11$0.11244 shs$4.48 million
11/07/2024$0.03$0.03
+0.37%
$0.03$0.03461 shs$1.16 million
11/06/2024$0.03$0.03
-0.18%
$0.03$0.03506 shs$1.15 million
11/05/2024$0.03$0.03
-0.18%
$0.03$0.031,993 shs$1.15 million
11/04/2024$0.03$0.03$0.03$0.03283 shs$1.16 million
11/01/2024$0.03$0.03$0.03$0.03122 shs$1.16 million
10/31/2024$0.03$0.03
+0.37%
$0.03$0.03603 shs$1.16 million
10/30/2024$0.03$0.03$0.03$0.034,668 shs$1.15 million
10/29/2024$0.06$0.03
-53.04%
$0.03$0.034,668 shs$1.15 million
10/28/2024$0.06$0.06$0.06$0.0638 shs$2.45 million
10/25/2024$0.06$0.06$0.06$0.066 shs$2.45 million
10/24/2024$0.06$0.06$0.06$0.062,405 shs$2.45 million
10/23/2024$0.03$0.06
+112.96%
$0.06$0.062,405 shs$2.45 million
10/22/2024$0.03$0.03$0.03$0.03274 shs$1.15 million
10/21/2024$0.03$0.03$0.11$0.031,471 shs$1.15 million


This page (NASDAQ:ADXS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners